SCHEMBL4450324

SCHEMBL4450324

COCC=Cc1ccc(C=CCOC)c(C=CCOC)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ APP P05067 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ BACE1 P56817 1/20 0.34
▸ CYP1A1 P04798 5/20 0.34
▸ CYP1B1 Q16678 5/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ CYP1A2 P05177 3/20 0.33
▸ IDO1 P14902 2/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ NFE2L2 Q16236 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ NR1H4 Q96RI1 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ MAOA P21397 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28707673 1.00 IRAK4 (0.41) IRAK4APPMAPTBACE1CYP1A1
SCHEMBL29268893 0.98 IRAK4 (0.40) IRAK4APPMAPTBACE1CYP1A1
SCHEMBL29137842 0.78 APP (0.49) APPIDO1AKT1NFE2L2
SCHEMBL17345596 0.78 IRAK4 (0.37) IRAK4MAPTALDH1A1MAOA
SCHEMBL6711813 0.77 AKT1 (0.46) CYP1A1CYP1B1PDE3BPDE3ACYP1A2
SCHEMBL28721892 0.76 ALDH1A1 (0.46) MAPTCYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL1682628 0.76 CYP1A1 (0.58) APPMAPTCYP1A1CYP1B1CYP1A2
SCHEMBL13679707 0.74 RELA (0.52) MAPTIDO1NFE2L2ALOX5MAOA
SCHEMBL6545108 0.72 KDM4E (0.57) MAPTCYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL16070662 0.72 TUBB4A (0.46) MAPTCYP1A2IDO1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116554397-A Negative electrode binder of lithium battery and preparation method thereof 深圳市德泰能源有限公司 2023-08-08 — — CN claimed
CN-110940756-B Method for evaluating quality of rhizoma acori graminei 陕西中医药大学 2021-10-01 — — CN claimed
CN-110940756-A Method for evaluating quality of rhizoma acori graminei by using one-test-multiple evaluation method 陕西中医药大学 2020-03-31 — — CN claimed
CN-116273085-B Nanometer copper vanadate-carbon nitrogen composite catalyst and preparation method and application thereof 南京航空航天大学 2024-07-09 — — CN disclosed
CN-118059089-A Aromatic and anti-influenza prescription volatile oil preparation for preventing influenza and preparation method and application thereof 中国中医科学院中医临床基础医学研究所 2024-05-24 — — CN disclosed
CN-116554397-A Negative electrode binder of lithium battery and preparation method thereof 深圳市德泰能源有限公司 2023-08-08 — — CN disclosed
CN-116273085-A Nanometer copper vanadate-carbon nitrogen composite catalyst and preparation method and application thereof 南京航空航天大学 2023-06-23 — — CN disclosed
CN-115850030-A Method for synthesizing cyclobutane lignans by utilizing visible light-silver salt heterogeneous photocatalysis 山东大学 2023-03-28 — — CN disclosed
CN-111778165-B Aspergillus niger DFY1 and application thereof 哈尔滨工业大学 2022-10-25 — — CN disclosed
CN-112791072-B Asarin nanocrystallization method 中国药科大学 2022-04-08 — — CN disclosed
CN-110940756-B Method for evaluating quality of rhizoma acori graminei 陕西中医药大学 2021-10-01 — — CN disclosed
CN-110934828-A Asarone oral emulsion and preparation method thereof 桂林南药股份有限公司 2020-03-31 — — CN disclosed
CN-110940756-A Method for evaluating quality of rhizoma acori graminei by using one-test-multiple evaluation method 陕西中医药大学 2020-03-31 — — CN disclosed
CN-110840866-A Asarin pharmaceutical composition and application thereof in preventing and treating neurodegenerative diseases 成都新睿泰康科技有限公司 2020-02-28 — — CN disclosed
CN-103142515-B Asarone injection and preparation method thereof ZHANG RUI 2015-02-18 — — CN disclosed
CN-103142515-A Asarone injection and preparation method thereof ZHANG RUI 2013-06-12 — — CN disclosed
US-7534454-B2 comprises of sterilized dried plant powder/extracts together with the conventional additives to form the oral dosage forms, which include tablets, capsules, syrup and powders ready for suspension and mouth spray KARERAT ARUN KUMAR 2009-05-19 — — US disclosed
US-20060137702-A1 comprises of sterilized dried plant powder/extracts together with the conventional additives to form the oral dosage forms, which include tablets, capsules, syrup and powders ready for suspension and mouth spray COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2006-06-29 — — US disclosed
WO-2006061848-A1 ANTICIGARETTE HERBAL FORMULATION AS AN ANTI-DOTE TO TOBACCO COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-06-15 — — WO disclosed
US-6388081-B1 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries LION BIOSCIENCE AG (DE) 2002-05-14 — — US disclosed
Send feedback